Trial intelligence / Profile preview

TEMP-prevent trial of etidronate in young adults with pseudoxanthoma elasticum

NL-OMON54216Phase 3Recruiting

Sponsor
University Medical Center Utrecht
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pseudoxanthoma elasticum (PXE) comparing Etidronate with Placebo (2 arms). Started Apr 2023; status: recruiting.

02

Drugs

etidronate
03

Conditions

pseudoxanthoma elasticum (PXE)

Beyond the preview

Go deeper on NL-OMON54216.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON54216.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call